BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35432282)

  • 1. Short-Term Metformin Treatment Enriches
    Robeson MS; Manna K; Randolph C; Byrum S; Hakkak R
    Front Microbiol; 2022; 13():834776. PubMed ID: 35432282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of obesity and 10 weeks metformin treatment on liver steatosis.
    Hakkak R; Rose S; Spray B; Kozaczek M; Korourian S
    Biomed Rep; 2021 Jun; 14(6):49. PubMed ID: 33859820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of gut microbiota populations in lean and obese Zucker rats.
    Hakkak R; Korourian S; Foley SL; Erickson BD
    PLoS One; 2017; 12(7):e0181451. PubMed ID: 28704522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Metformin Treatment on Serum Metabolic Profile Changes in Lean and Obese Zucker Rat Model for Fatty Liver Disease.
    Melnyk S; Hakkak R
    Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats.
    Hakkak R; Spray B; Børsheim E; Korourian S
    Front Nutr; 2022; 9():913571. PubMed ID: 35811988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
    Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
    Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis.
    Yoshida N; Emoto T; Yamashita T; Watanabe H; Hayashi T; Tabata T; Hoshi N; Hatano N; Ozawa G; Sasaki N; Mizoguchi T; Amin HZ; Hirota Y; Ogawa W; Yamada T; Hirata KI
    Circulation; 2018 Nov; 138(22):2486-2498. PubMed ID: 30571343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A diet containing a high- versus low-daidzein level does not protect against liver steatosis in the obese Zucker rat model.
    Bell A; Korourian S; Zeng H; Phelps J; Hakkak R
    Food Funct; 2017 Mar; 8(3):1293-1298. PubMed ID: 28244519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats.
    Zhang M; Feng R; Yang M; Qian C; Wang Z; Liu W; Ma J
    BMJ Open Diabetes Res Care; 2019; 7(1):e000717. PubMed ID: 31641523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis.
    Huang SW; Ou YC; Tang KS; Yu HR; Huang LT; Tain YL; Lin IC; Sheen JM; Hou CY; Tsai CC; Tiao MM
    Lipids Health Dis; 2021 Sep; 20(1):100. PubMed ID: 34496884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies.
    Cao TTB; Wu KC; Hsu JL; Chang CS; Chou C; Lin CY; Liao YM; Lin PC; Yang LY; Lin HW
    Front Endocrinol (Lausanne); 2020; 11():573891. PubMed ID: 33071980
    [No Abstract]   [Full Text] [Related]  

  • 12. A rosemary extract rich in carnosic acid selectively modulates caecum microbiota and inhibits β-glucosidase activity, altering fiber and short chain fatty acids fecal excretion in lean and obese female rats.
    Romo-Vaquero M; Selma MV; Larrosa M; Obiol M; García-Villalba R; González-Barrio R; Issaly N; Flanagan J; Roller M; Tomás-Barberán FA; García-Conesa MT
    PLoS One; 2014; 9(4):e94687. PubMed ID: 24733124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Immunobiotics
    Song L; Huang Y; Liu G; Li X; Xiao Y; Liu C; Zhang Y; Li J; Xu J; Lu S; Ren Z
    Front Immunol; 2021; 12():828887. PubMed ID: 35154087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
    Raju J; Bird RP
    Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the gut microbiota after metformin intervention in children with obesity: A metagenomic study of a randomized controlled trial.
    Pastor-Villaescusa B; Plaza-Díaz J; Egea-Zorrilla A; Leis R; Bueno G; Hoyos R; Vázquez-Cobela R; Latorre M; Cañete MD; Caballero-Villarraso J; Gil Á; Cañete R; Aguilera CM
    Biomed Pharmacother; 2021 Feb; 134():111117. PubMed ID: 33360047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats.
    Raju J; Bird RP
    Cancer Res; 2003 Oct; 63(20):6595-601. PubMed ID: 14583451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome alterations in colitis rats after moxibustion at bilateral Tianshu acupoints.
    Qi Q; Liu YN; Lv SY; Wu HG; Zhang LS; Cao Z; Liu HR; Wang XM; Wu LY
    BMC Gastroenterol; 2022 Feb; 22(1):62. PubMed ID: 35151255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes.
    Davis-Richardson AG; Ardissone AN; Dias R; Simell V; Leonard MT; Kemppainen KM; Drew JC; Schatz D; Atkinson MA; Kolaczkowski B; Ilonen J; Knip M; Toppari J; Nurminen N; Hyöty H; Veijola R; Simell T; Mykkänen J; Simell O; Triplett EW
    Front Microbiol; 2014; 5():678. PubMed ID: 25540641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial.
    Ejtahed HS; Tito RY; Siadat SD; Hasani-Ranjbar S; Hoseini-Tavassol Z; Rymenans L; Verbeke K; Soroush AR; Raes J; Larijani B
    Eur J Endocrinol; 2019 Mar; 180(3):165-176. PubMed ID: 30540558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats.
    Livingstone DE; Kenyon CJ; Walker BR
    J Endocrinol; 2000 Dec; 167(3):533-9. PubMed ID: 11115781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.